• Skip to primary navigation
  • Skip to main content
Rebiotix Logo

Rebiotix

Powerful Therapy Delivered

  • Home
  • About
    • Senior Management
    • Stool Donor Program
    • Careers and Employment
  • Our Therapy
    • The Human Microbiome
    • Microbiota Restoration Therapy
    • Clostridioides difficile Infection
    • The Future of Microbiome-Based Therapeutics
  • Clinical Trials
    • RBX2660 Clinical Trials
    • RBX7455 Clinical Evaluation
    • Physician-sponsored Studies
    • Patient Resources
    • Expanded Access Policy
  • Science
    • Congress Publications
    • Manuscripts and Whitepapers
    • Related Evidence
  • Media
    • Latest Press Releases
    • Frequently Asked Questions
    • “Rebiotix” in the News
    • Conferences
    • Media Tools
    • Presentations & Videos
    • Contacts
  • Contact Us
  • Show Search
Hide Search

White Papers Microbiota Restoration Therapy

The Human Microbiome: A New Frontier in Drug Discovery

Published Summer 2016 Lee Jones, CEO, Rebiotix Inc. There is a new phenomenon sweeping the globe (or at least sweeping the imagination of people around the globe). It is the human gut microbiome and the role it may play in the future of human health. Page One of Six Recent reports have indicated that the […]

What’s Next for the Microbiome: View from Industry

Published June 2015 Complete Text The human microbiome has generated a lot of excitement around its potential to treat disease. Papers about the human microbiome are being published at an increasing pace, some holding out the promise of providing answers to vexing medical problems such as Clostridium difficile infection (CDI), autism, Parkinson’s disease, multiple sclerosis and others. […]

Interested in Becoming a Stool Donor? Learn More

Rebiotix

  • Copyright © 2022 Rebiotix, Inc.
  • A Ferring Company
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • Contact Us